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Abstract
The health sector consistently appears prominently in surveys of perceived corruption, with considerable 
evidence that this has serious adverse consequences for patients. Yet this issue is far from prominent in the 
international health policy discourse. We identify five reasons why the health policy community has been 
reluctant to talk about it. These are the problem of defining corruption, the fact that some corrupt practices 
are actually ways of making dysfunctional systems work, the serious challenges to researching corruption, 
concerns that a focus on corruption is a form of victim blaming that ignores larger issues, and a lack of evidence 
about what works to tackle it. We propose three things that can be done to address this situation. First, seek 
consensus on the scale and nature of corruption. Second, decide on priorities, taking account the importance of 
the particular problem and the feasibility of doing something about it. Third, take a holistic view, drawing on a 
wide range of disciplines.
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Some things are rarely discussed in public. Quite reasonably, most of us, if we are not among the growing number of social media celebrities, believe that the 
more intimate aspects of our personal relationships remain 
private. We can reasonably argue that they are of no concern 
to anyone else. But there are some things that take place 
in private, and which traditionally remained secret, that 
are at last being discussed openly because they do concern 
others. Sexual abuse and exploitation by those in positions 
of power exemplify such things. For too long, even though 
such behaviour was known about, it was tacitly accepted and 
few were sufficiently brave to talk about it. Those that did, 
especially if they were the victims, often suffered from doing 
so. They came to realise that actions that were, by any moral 
or ethical framework, wrong were simply accepted. That was 
the way things had always been, and would always be in the 
future. Quite simply, nothing could be done. 
Yet something can be done. The #MeToo movement has 
empowered the victims of such abuse to speak out, holding 
the perpetrators to account. Now, it is the abusers who find 
themselves excluded. This does not mean that the problem 
has been solved. Few things are. Slavery was abolished in 
much the world more than 150 years ago but there are still 
hundreds of thousands of forced and indentured labourers 
and, in a few countries, slaves. But at least by talking about 
abuses of different kinds, it is possible to begin the process of 
changing things.
The #MeToo scandals are most closely identified with the 
arts world, although medicine is not immune.1 Yet we, in the 
health policy community, have our own dirty secret.2 It is 
something that we all know exists but we are often too polite 
to talk about it. It is corruption in the health sector. Too often, 
we spend long hours discussing why something that should 
work in theory does not work in practice, without asking 
who benefits from the status quo. Or why, despite investing in 
extra staff and facilities, many people still struggle to get the 
care they need, without asking where those staff are and what 
they are doing with the resources provided for them. 
Our failure to confront this issue is all the more surprising 
given that surveys, such as those conducted by Transparency 
International, consistently find that the health sector is 
among the most corrupt in many countries. In its 2013 
“corruption barometer” it reported that, in 42 of 109 countries 
surveyed, over 50% of citizens viewed their health systems 
as corrupt or very corrupt.3 Scholars have also developed 
detailed frameworks that describe the main manifestations 
of corruption in the health sector.4,5 We also know that this 
has consequences. It undermines the trust that underpins 
effective, equitable, and responsive healthcare.6 It also costs 
lives, with a 2011 study estimating that about 140 000 child 
deaths annually could be attributed to corruption.7 Yet when 
health ministers describe their achievements, both real 
and anticipated, at international meetings, while they will 
sometimes be frank and admit to specific failures, using them 
to discuss the lessons they have learned, they rarely discuss 
the role of corruption and the weaknesses of governance that 
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often underlies it. 
A new paper from a group of authors from North American 
universities makes the case for a renewed drive to tackle this 
issue. They argue that the Sustainable Development Goals 
(SDGs), which the governments of the world have committed 
to achieving by 2030, and including policies in a wide range 
of areas, could be leveraged to tackle corruption in the health 
sector.8 They showed how corrupt practices were likely to 
impede progress on several of the health-related SDGs, such 
as universal health coverage, but also how SDGs in other 
areas, such as SDG 16 (Peace, Justice and Strong Institutions) 
and 17 (Partnerships) offer means by which action might be 
mobilised.
As researchers working on an international project on 
corruption, in which we are focusing on the health sector, we 
have been reflecting on why it is that these conversations are 
so difficult to hold. We have identified five main reasons.
First, it is difficult to define corruption. Indeed, practices 
that are clearly corrupt are often described in other words. 
Even in one language, English, these include, for example, 
backhander, bribery, exploitation, extortion, fiddling, fraud, 
graft, nepotism, jobbery, payola, profiteering, racketeering, 
and skimming. Others, in languages other than English, have 
also gained international currency, even if their meaning 
has changed in the process. An example is baksheesh, which 
has evolved from its original meaning of charitable giving in 
Persian (ششخب ). “Dash”, used widely in West Africa, is believed 
to originate in the Portuguese word doação, or giving of gifts. 
Others are widely used in certain regions but have not spread 
widely elsewhere, such as the Urdu word rishwat (توشر), used 
widely throughout the Indian sub-continent.
The United Nations Convention against Corruption does 
not try to define its subject, instead, simply listing a number of 
corrupt practices.9 The Cochrane Collaboration, in its review 
of measures effective in reducing corruption, did.10 It defines 
corruption as “The abuse or complicity in abuse, of public or 
private position, power or authority to benefit oneself, a group, 
an organization or others close to oneself; where the benefits 
may be financial, material or non-material.” This can take 
many forms, not all of which may be recognized as corruption 
by everyone.4,11 For example, irregularities in procurement 
of medical consumables and equipment, especially where 
these involved bribes, would probably be accepted by most 
people as corrupt. But what about the widespread practice of 
inducements, some of little monetary value, such as pens, by 
pharmaceutical sales representatives?12 There is considerable 
evidence that this is associated with increased prescribing of 
the brands concerned.13 Then there are informal payments, 
made to secure faster or higher quality treatment.14-16 Again, 
the corrupt nature may be obvious, but where is the dividing 
line from unsolicited tokens of gratitude? Theft of drugs or 
equipment from public facilities to be used in private ones 
is clearly corrupt, as it denies them to those in the public 
facilities. But what about absenteeism or late arrival or early 
departure from work in the same public facility, which also 
denies patients an essential component of care, the time of the 
health worker?17,18 
Second, some practices that seem corrupt may actually 
be seen by those concerned, both providers of services and 
their beneficiaries, as the only means of enabling some fragile 
health systems simply to keep working. Health professionals 
may feel they have no alternative to bribe officials to obtain 
necessary authorisations to function. The recipients of the 
bribes are clearly corrupt, but what about those offering them? 
Informal payments extracted from those with the ability to 
pay may be channelled into the operation of the health facility 
rather than the pocket of the health worker, thereby allowing 
those who cannot afford payments to be treated. Should they 
be condemned for this? More generally, is there a danger that 
efforts to remove corruption without addressing the other 
weaknesses in the health system might threaten the delivery 
of care further and hurt the most vulnerable? 
Third, how do we conduct research on corruption in ways 
that capture what is really happening? It is very easy for those 
involved in graft to shift blame to other, less powerful actors as 
corrupt and deflect attention from themselves. How does one 
engage in anti-corruption research without colluding with 
corrupt officials, for example when the researcher observes 
abusive or exploitative behaviour but seeks to maintain the 
access necessary to report it, a dilemma recognised in other 
settings where there are power imbalances?19 
Fourth, is it even legitimate to study corruption? There is a 
view in some quarters that concerns about corruption divert 
attention from more important issues, such as the unequal 
distribution of global resources, itself a factor in the emergence 
and persistence of corruption. Some of those adopting this 
paradigm see a focus on corruption as a manifestation of the 
neoliberal attack on the state,20 noting how it was prioritized 
by development agencies in the 1980s during the Reagan-
Thatcher era, when many public health systems were being 
dismantled. 
Finally, we still know far too little about how to tackle 
corruption. Despite years of investment in good governance, 
levels of corruption remain high and, in some places, growing. 
The Cochrane review found no studies meeting their criteria 
that provided empirical evidence of effects of strategies 
to reduce corruption and only nine that could be used to 
describe the range of strategies that have been tried that could 
guide future evaluations of promising strategies, even if there 
is insufficient evidence so far.10 
So, what can be done to address these problems and initiate 
a debate on corruption in health systems? A first step is to 
convene key stakeholders in the health system, including 
policy makers, health professionals, and managers, to seek 
agreement on the scale and nature of corruption in each health 
system. The challenges are, however, formidable. There will 
often be a considerable reluctance to speak openly, especially 
by those who are disempowered. Such individuals will need 
considerable support and, in some cases, protection if they are 
to expose corrupt practices. 
Second, and once agreement has been reached on the 
problem, it will be necessary to prioritize action. Decisions 
should be guided by both the impact on the health system, 
and especially on vulnerable groups, and the existence of a 
potential remedy that has some feasibility of success. Some 
corrupt practices may not matter much while others might 
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pose severe threats to health. Some may even be rational 
responses to a dysfunctional system. Sometimes, the choice 
will be helped by the opening of a window of opportunity. 
It will be very important to understand the reasons why 
corrupt practices thrive, constantly asking questions about 
who benefits in different ways and what are the underlying 
causes and the extent to which they can be changed. By 
understanding the incentives that operate, including the 
use of corrupt practices to overcome unnecessary structural 
and organizational barriers, it may be possible to develop 
pragmatic solutions that can command approval.21 Drawing 
on Kingdon’s work on policy streams, it is important to 
concentrate on what matters most and can most easily be 
addressed at a particular time.22 
Third, as with many complex problems, it is essential to take 
a holistic view. Research on corruption in the health sector 
is often published in specialist anthropology and political 
economy journals and much less in the health literature. 
This means that it is largely absent from the main databases 
covering health systems, PubMed and EconLit, or if it is there 
it is difficult to find, perhaps because the term “corruption” 
is seen as judgmental and thus avoided in some cases. There 
is a clear need for a multi-disciplinary response, yet many 
countries where corruption is widespread lack traditions of 
multi-disciplinary working, which exacerbates their other 
problems related to limited research capacity. It is entirely 
understandable if researchers decide that they would rather 
study less contentious and, in some cases dangerous topics.
Finally, it is important that the research community sets 
out what it can offer. Zyglidopoulos et al identify four broad 
paths for research on corruption, in: (1) individuals, (2) 
organizations and industries, (3) different countries (largely 
from an economic development perspective), and (4) different 
cultural contexts (from an anthropological perspective).23 
This work draws on a range of disciplines, including social 
psychology,24 criminology,25 development economics,26 and 
even media studies, such as that asking why a corrupt activity 
becomes a scandal.27 Now is an especially propitious time 
to do this, taking advantage of new opportunities, many of 
which fall within the umbrella of “big data,”28 using tools such 
as social network analysis.29,30 
In writing this editorial, we hope to encourage a wider 
conversation about corruption in the health sector. This topic 
has failed to engage most global policy-makers, who seem to 
put it in the “too difficult” tray. Only a few groups, such as 
Transparency International, are campaigning for it to receive 
attention. Clearly, much could be done already, even without 
further research, where the political will exists. Yet, there is 
also a clear need for research, to ensure that policies adopted 
take account of the prevailing context and actually work, 
avoiding the risk of unintended consequences. A first step is 
to agree on a possible research agenda is lacking. 
Above all, even if corruption is not yet spoken about 
publicly in the corridors of power, we know that it exists 
and is widespread. If we are to achieve the health-related 
SDGs, we must have that conversation within and among 
the many stakeholders within countries and the international 
community. 
Acknowledgements
This editorial is an expanded version of a blog by the 
authors on corruption, available at https://ace.soas.ac.uk/
five-reasons-corruption-health/. It is an output of the SOAS 
Anti-Corruption Evidence (ACE) research consortium 
funded by UK Aid from the UK Government [Contract P0 
7073]. The views presented in this publication are those of the 
authors and do not necessarily reflect the UK government’s 
official policies or the views of SOAS-ACE or other partner 
organisations. For more information on SOAS-ACE visit 
https://ace.soas.ac.uk.
Ethical issues
Not applicable.
Competing interests
Authors declare that they have no competing interests. 
Authors’ contributions
MM drafted the paper, which EH and DB revised. 
Authors’ affiliations
1Department of Global Health and Development, London School of Hygiene and 
Tropical Medicine, London, UK. 2Department of Public Health & Policy, London 
School of Hygiene and Tropical Medicine, London, UK.
References
1. Jagsi R. Sexual Harassment in Medicine - #MeToo. N Engl J Med. 
2018;378(3):209-211. doi:10.1056/NEJMp1715962
2. Jain A, Nundy S, Abbasi K. Corruption: medicine’s dirty open secret. 
BMJ. 2014;348:g4184. doi:10.1136/bmj.g4184
3. Transparency International . Global corruption barometer 2013 
report. https://www.transparency.org/gcb2013. Accessed October 
31, 2018. Published 2013.
4. Vian T. Review of corruption in the health sector: theory, methods 
and interventions. Health policy planning. 2008;23(2):83-94. 
5. Petkov M, Cohen D. Diagnosing corruption in health care. 
https://www.transparency.org.uk/wp-content/plugins/download-
attachments/includes/download.php?id=5804. Accessed October 
31, 2018. Published 2016.
6. Berger D. Corruption ruins the doctor-patient relationship in India. 
BMJ. 2014;348:g3169. 
7. Hanf M, Van-Melle A, Fraisse F, Roger A, Carme B, Nacher M. 
Corruption kills: estimating the global impact of corruption on 
children deaths. PLoS One. 2011;6(11):e26990. doi:10.1371/
journal.pone.0026990
8. Mackey TK, Vian T, Kohler J. The sustainable development goals as 
a framework to combat health-sector corruption. Bull World Health 
Organ. 2018;96(9):634-643. doi:10.2471/blt.18.209502
9. United Nations. Convention against Corruption. New York: United 
Nations; 2003. 
10. Gaitonde R, Oxman AD, Okebukola PO, Rada G. Interventions to 
reduce corruption in the health sector. Cochrane Database Syst 
Rev. 2016(8):Cd008856. doi:10.1002/14651858.CD008856.pub2
11. Vian T, Nordberg C. Corruption and the health sector. Bergen: Anti-
Corruption Resource Centre, CHR Michelsen Institute; 2002. 
12. Fadlallah R, Alkhaled L, Brax H, et al. Extent of physician-
pharmaceutical industry interactions in low- and middle-income 
countries: a systematic review. Eur J Public Health. 2018;28(2):224-
230. doi:10.1093/eurpub/ckx204
13. Fickweiler F, Fickweiler W, Urbach E. Interactions between 
physicians and the pharmaceutical industry generally and sales 
representatives specifically and their association with physicians’ 
attitudes and prescribing habits: a systematic review. BMJ Open. 
2017;7(9):e016408. doi:10.1136/bmjopen-2017-016408
14. Balabanova D, McKee M. Understanding informal payments for 
health care: the example of Bulgaria. Health Policy. 2002;62(3):243-
273. 
Hutchinson et al
International Journal of Health Policy and Management, 2019, 8(4), 191–194194
15. Gaal P, Belli PC, McKee M, Szocska M. Informal payments for 
health care: definitions, distinctions, and dilemmas. J Health Polit 
Policy Law. 2006;31(2):251-293. doi:10.1215/03616878-31-2-251
16. Lewis M. Informal payments and the financing of health care 
in developing and transition countries. Health Aff (Millwood). 
2007;26(4):984-997. doi:10.1377/hlthaff.26.4.984
17. Lindelow M, Serneels P. The performance of health workers 
in Ethiopia: results from qualitative research. Soc Sci Med. 
2006;62(9):2225-2235. doi:10.1016/j.socscimed.2005.10.015
18. Garcia-Prado A, Chawla M. The impact of hospital management 
reforms on absenteeism in Costa Rica. Health Policy Plan. 
2006;21(2):91-100. doi:10.1093/heapol/czj015
19. Randall D, Anderson A, Taylor J. Protecting children in research: 
Safer ways to research with children who may be experiencing 
violence or abuse. J Child Health Care. 2016;20(3):344-353. 
doi:10.1177/1367493515587060
20. Bedirhanoğlu P. The neoliberal discourse on corruption as a means 
of consent building: reflections from post-crisis Turkey. Third World 
Quarterly. 2007;28(7):1239-1254. 
21. Khan MH. Introduction: Political Settlements and the Analysis of 
Institutions. Afr Aff (Lond). 2018;117(469):636-655.
22. Kingdon JW, Thurber JA. Agendas, alternatives, and public policies. 
Boston: Little, Brown 1984. 
23. Zyglidopoulos S, Hirsch P, Martin de Holan P, Phillips N. 
Expanding Research on Corporate Corruption, Management, and 
Organizations. Los Angeles, CA: SAGE Publications; 2017.
24. Anand V, Ashforth BE, Joshi M. Business as usual: The acceptance 
and perpetuation of corruption in organizations. Acad Manag 
Perspect. 2004;18(2):39-53. 
25. Anechiarico F, Jacobs JB, Jacobs JB. The pursuit of absolute 
integrity: How corruption control makes government ineffective. 
Chicago, IL: University of Chicago Press; 1996. 
26. Wedeman A. Looters, rent-scrapers, and dividend-collectors: 
Corruption and growth in Zaire, South Korea, and the Philippines. J 
Dev Areas. 1997;31(4):457-478. 
27. Hirsch PM, Milner D. When scandals yield “it’s about time!” Rather 
than “We’re shocked and surprised!.” Journal of Management 
Inquiry. 2016;25(4):447-449. 
28. Hlatshwayo S, Oeking A, Ghazanchyan MM, Corvino D, Shukla A, 
Leigh MLY. The Measurement and Macro-Relevance of Corruption: 
A Big Data Approach. Washington DC: International Monetary Fund; 
2018. 
29. Diviák T, Dijkstra JK, Snijders TA. Structure, multiplexity, and 
centrality in a corruption network: the Czech Rath affair. Trends 
Organ Crime. 2018. doi:10.1007/s12117-018-9334-y
30. Colladon AF, Remondi E. Using social network analysis to prevent 
money laundering. Expert Syst Appl. 2017;67:49-58.
